作者: Dong Wang , Shao-qin Zheng , Yong Zeng , Hai-bin Chen , Ying-ming Yang
DOI: 10.1016/J.JNS.2015.05.032
关键词:
摘要: Abstract Glioma is the most common and aggressive primary brain tumor in clinic. Due to its high heterogeneity not-fully understood pathogenesis, progress of clinical treatment glioma slow. Current studies have demonstrated that Ets-1 (E26 tansformation-specific-1) a proto-oncogene. Our immunohistochemical analysis indicated expression level tissues was significantly higher than normal ( P